Dulaglutide Versus Liraglutide in Obese Type 2 Diabetic Adolescents Using Metformin

Corporacion Parc Tauli

Status: Completed

Conditions: Type 2 Diabetes Treated With Insulin; Obesity; Adolescent Obesity

Treatments: Drug: Liraglutide; Drug: Dulaglutide

Study type: Interventional

Funder types: Other

Identifiers

NCT04829903

DULACAI37628

Details and patient eligibility

About

To compare the efficacy and effect on glycemic control of Dulaglutide versus Liraglutide in obese Type 2 diabetic adolescents using metformin

Full description

To observe the efficacy, effect on glycemic control, impact on BMI and incidence of adverse effects of Dulaglutide and to compare it to Liraglutide in individuals aged thirteen to eighteen who have Type 2 diabetes mellitus and are obese.

Enrollment: 116 patients

Sex: All

Ages: 12 to 19 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 Diabetes Mellitus
• Obese
• Taking metformin
• Male or female

Exclusion criteria

• Non obese
• Not taking metformin
• Taking other injectable diabetic medications

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

116 participants in 2 patient groups, including a placebo group

Group DUL

Active Comparator group

Description:

Group taking Dulaglutide injections

Treatment:

Drug: Dulaglutide

Group LIR

Placebo Comparator group

Description:

Group taking Liraglutide injections

Treatment:

Drug: Liraglutide